Undifferentiated embryonal sarcoma of liver

Avyakta Kallam, Jairam Krishnamurthy, Jessica Kozel, Nicole Shonka

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Undifferentiated embryonal sarcoma of the liver (UESL) is a rare malignant hepatic tumor. A 47 year old male presented with symptoms of sour taste in his mouth, occasional nausea, indigestion and 15-pound weight loss over two months. He had an unremarkable upper gastrointestinal endoscopy. Imaging showed a large liver mass in the left hepatic lobe that was resected and then reported as UESL. He went on to develop lung metastases and was initially treated with doxorubicin and ifosfamide followed by switching of therapy to gemcitabine and docetaxel due to progression of disease. He had a good response after two cycles and went on to receive four more cycles, achieving stable disease. We can therefore conclude that the combination of gemcitabine and docetaxel is a potential therapeutic option for patients with UESL.

Original languageEnglish (US)
Article number6009
Pages (from-to)130-132
Number of pages3
JournalRare Tumors
Issue number4
StatePublished - Dec 30 2015


  • Embryonal
  • Liver
  • Sarcoma

ASJC Scopus subject areas

  • Histology
  • Oncology


Dive into the research topics of 'Undifferentiated embryonal sarcoma of liver'. Together they form a unique fingerprint.

Cite this